Effectiveness of Point of Care Blood Analysis Obtained From Skin Puncture Blood

April 14, 2017 updated by: Changsun Kim, Hanyang University

Correlation Between the Point of Care Blood Analysis Obtained From Skin Puncture Blood and Conventional Blood Analysis Obtained From Venous and Arterial Blood

This study aimed to evaluate the correlation between the point of care blood analysis obtained from skin puncture blood and conventional blood analysis obtained from venous and arterial blood.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
    • GyeongGido
      • Guri, GyeongGido, Korea, Republic of, 471-701
        • Hanyang university guri hospital, Department of emergency medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The patients who require the blood test (venous blood test, skin puncture blood test and arteria blood gas analysis) of the patients presenting to the emergency department during the study period

Description

Inclusion Criteria:

  • The patients who simultaneously require the venous blood test, skin puncture blood test and arterial blood gas analysis

Exclusion Criteria:

  • Unstable patients
  • Patients receiving the medications affecting the results of blood analysis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Blood test group
All patients receive the three types of blood test (venous blood test, skin puncture blood (capillary blood) test and arterial blood gas analysis
Diagnostic test: blood test
Point of care blood analysis obtained from skin puncture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood analysis between capillary blood, venous blood and arterial blood
Time Frame: within 1 hour

Primary outcome

  1. Correlation of blood concentration between skin puncture blood and venous blood

    • variables Na+ (mmol/L) K+ (mmol/L) Ca++ (mmol/L) Hct (%) Glucose (mg/dl) Creatinine (mg/dl) Cl- (mmol/L)

  2. Correlation of blood concentration between skin puncture blood and arterial blood

    • variables pH pCO2 (mmHg) pO2 (mmHg) HCO3 (mmol/L) Lactate (mmol/L)

Spearman correlation rank test will be performed to show the agreement of two methods in each value.

We will show the correlation coefficient for all values. Ex) The correlation coefficient of Na+, K+, Ca2+, Hct, glucose, creatinine and Cl- are ___, ___, ___, ___, ___, ___, ___, respectively.
within 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hanyang University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2017

Primary Completion (Anticipated)

September 30, 2017

Study Completion (Anticipated)

September 30, 2017

Study Registration Dates

First Submitted

March 14, 2017

First Submitted That Met QC Criteria

March 29, 2017

First Posted (Actual)

March 30, 2017

Study Record Updates

Last Update Posted (Actual)

April 18, 2017

Last Update Submitted That Met QC Criteria

April 14, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SKINFUNCTURE2017

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on blood test

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe